Rexam Healthcare Expands Manufacturing for Drug Delivery Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rexam Healthcare Expands Manufacturing for Drug Delivery Systems


Rexam Healthcare, a subsidiary of the UK group Rexam, will expand manufacturing capabilities at its French site in Le Tréport, Seine Maritime, the company announced in a press release.

This site specializes in drug delivery systems, including the recently introduced Advancia pump for the nasal-spray sector. The plant expansion and the Advancia project, which is supported by the European Regional Development Fund in Normandy, will add approximately fifty jobs.
 
Along with other site improvements, the manufacturing expansion will include a production building with a 2900-square meter cleanroom and 1500 square meters housing the machine and mold maintenance workshops, metrology unit, laboratory, and administrative premises. The cleanroom is expected to open in November 2013 and full inauguration of the site is expected in early 2014.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here